Novo has returned for Milestone's latest round, having led its $55m series C last year, helping the cardiovascular drug developer's total funding to $167m.

Amazon, Eon and Čez Group have backed a $50m funding round for smart thermostat manufacturer Tado that nearly doubled its equity to $102m.

Bristol Myers-Squibb, Merck Group and Novo all took part in a $90m series C round for Galecto Biotech, which is commercialising research from Lund and Edinburgh universities.

Bristol Myers-Squibb, Merck Group and Novo all took part in a $90m series C round for Galecto Biotech that was co-led by Ysios Capital and OrbiMed.

China Life's Healthcare Fund led the series B-1 round, which followed a series B featuring fellow corporates Google and Tencent in January.

The employee training software provider has confirmed a $50m round that included SIG, the corporate that led its series B round in 2017.

Yellowbrick Data has raised $48m in a round led by Siemens' Next47 unit, adding to the $44m from investors including GV and Samsung Next it disclosed two months ago.

Flexible workspace provider Knotel increased its funding to $160m in two years, as Bloomberg Beta returned to reinvest and NVP kicked in $50m.

Walmart, Airbus, Softbank, Moody’s, Dimension Data, Nokia, Munich Re, Scotiabank, Barclays, M12 and Cisco Investments have all backed the cybersecurity company builder.

Alexandria Venture Investments invested in the genetic drug developer, which completed a series B round that followed a $40m series A in January.